Ke Hu
Hebei Medical University(CN)Nanjing Agricultural University(CN)The University of Sydney(AU)Anhui University of Science and Technology(CN)Shanghai University of Sport(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Peking Union Medical College Hospital(CN)China University of Geosciences (Beijing)(CN)Wuhan University(CN)Zhejiang Environmental Monitoring Center(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)Peking University First Hospital(CN)Renmin Hospital of Wuhan University(CN)Chongqing Medical University(CN)Capital Normal University(CN)
Publications by Year
Research Areas
Obstructive Sleep Apnea Research, Neuroscience of respiration and sleep, COVID-19 Clinical Research Studies, Chronic Obstructive Pulmonary Disease (COPD) Research, Long-Term Effects of COVID-19
Most-Cited Works
- → Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China(2020)741 cited
- → Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial(2020)461 cited
- → Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial(2008)278 cited
- → Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza(2011)258 cited
- → Clinical characteristics of 82 death cases with COVID-19(2020)249 cited
- → Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial(2010)